With about 11% of the US on a GLP-1 for weight loss, Mayo Clinic tackles how much loss is enough and what helps keep the weight off.
Recap by typeshit. Post by @mayoclinic on Instagram.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Robert Lufkin MD shares the observational data: an average 16.1 kg lost at six months among 7,297 women, with 62.7% reporting side effects.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Holly Lofton says some patients using gray-market reta saw no weight loss at all, since those products often lack the active ingredient. UK approval is still pending.
PBS News reports roughly one in eight Americans are on GLP-1 weight loss drugs and looks at what comes with their popularity.
Loading…